Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lucemyra
Marketing
Salix inks deal with Dova, 3rd recent deal to boost portfolio
Salix's latest deal not only beefs up its own portfolio, but gives Dova a co-promo boost for its newly minted chronic liver disease drug, Doptelet.
Beth Snyder Bulik
Oct 5, 2018 11:03am
Salix, US WorldMeds dial in Lucemyra launch
Aug 13, 2018 9:30am
Valeant signs on to hawk opioid withdrawal drug Lucemyra
Jun 28, 2018 10:54am
